Kathleen Borthwick, the Chief Financial Officer of Passage BIO, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines ...

Proceeds will support testing of drugs designed to suppress hunger in people with the tough-to-treat rare disease and, ...

Odyssey Therapeutics and Sionna Therapeutics have filed to carry out initial public offerings (IPOs) on the Nasdaq, taking the number in the newly-filed queue to four since the start of the year.

MBX plans to list on the Nasdaq under the symbol MBX. The recent flurry of IPOs adds to the sense that the environment for biotechs seeking to go public after a two-year lull, with a pick-up in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The initial public offering (IPO) of Solarium Green Energy kicks-off for bidding on today, that is Thursday, February 6 and the issue can be subscribed until Monday, February 10. The IPO of ...

2-Year U.S. Treasury Note Continuous Contract $102.664 0.000 0.00% 5-Year U.S. Treasury Note Continuous Contract $106.242-0.023-0.02% 10-Year U.S. Treasury Note Continuous Contract $108.922-0.047 ...

The NASDAQ refers to the National Association of Securities Dealers Automated Quotations exchange. It was the world’s first all-electronic stock exchange and is subject to the regulatory ...